{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:07:22Z","timestamp":1774980442287,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.clml.2016.02.039","type":"journal-article","created":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T13:56:18Z","timestamp":1456667778000},"page":"e55-e57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3723-7733","authenticated-orcid":false,"given":"Irina","family":"Panovska-Stavridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar","family":"Eftimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Ivanovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Pivkova-Veljanovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidija","family":"Cevreska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-4406","authenticated-orcid":false,"given":"Sylvie","family":"Hermouet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar J.","family":"Dimovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2016.02.039_bib1","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2008-03-077966","article-title":"Myeloproliferative disorders","volume":"112","author":"Levine","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.02.039_bib2","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2016.02.039_bib3","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.clml.2016.02.039_bib4","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations in calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2016.02.039_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/ejhg.2013.117","article-title":"Clinical utility gene card for: hereditary thrombocythemia","volume":"22","author":"Hussein","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.clml.2016.02.039_bib6","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMc1200349","article-title":"Germline JAK2 mutation in a family with hereditary thrombocytosis [letter]","volume":"366","author":"Mead","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2016.02.039_bib7","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood-2012-05-430926","article-title":"Impact of isolated germline JAK2V617I mutation on human hematopoiesis","volume":"121","author":"Mead","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.02.039_bib8","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia. JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clml.2016.02.039_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/mend.11.4.9907","article-title":"The leptin receptor activates Janus kinase 2 and signals for proliferation in a factor-dependent cell line","volume":"11","author":"Ghilardi","year":"1997","journal-title":"Mol.Endocrinol"},{"key":"10.1016\/j.clml.2016.02.039_bib10","first-page":"61","article-title":"Signaling via JAK tyrosine kinases: growth hormone receptor as a model system","volume":"53","author":"Carter-Su","year":"1998","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.clml.2016.02.039_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2350-12-166","article-title":"Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders","volume":"12","author":"Penas-Steinhardt","year":"2011","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.clml.2016.02.039_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2353\/jmoldx.2009.080114","article-title":"Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias","volume":"11","author":"Ma","year":"2009","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.clml.2016.02.039_bib13","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1128\/MCB.24.11.4968-4978.2004","article-title":"Tyrosine phosphorylation of Jak2 in the JH2 domain inhibits cytokine signaling","volume":"24","author":"Feener","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.clml.2016.02.039_bib14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1182\/blood-2015-07-661835","article-title":"Whole exome sequencing identifies novel MPL and JAK2 mutations in triple negative myeloproliferative neoplasms","volume":"127","author":"Milosevic Feenstra","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2016.02.039_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00277-014-2248-0","article-title":"A\u00a0report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients","volume":"94","author":"Xu","year":"2015","journal-title":"Ann Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265016000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:27:37Z","timestamp":1761870457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265016000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2152265016000999"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2016.02.039","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Essential Thrombocythemia Associated With Germline JAK2 G571S Variant and Somatic CALR Type 1 Mutation","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2016.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}